Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673373 · ClinicalTrials.gov registry record · NA
Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
A NA study, sponsored by Atrium Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01673373 is a NA study that has completed, run by Atrium Medical Corporation. The registered enrollment target is 68 participants.
The verdict
NCT01673373, a NA study, has completed, sponsored by Atrium Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.
Interventions
- DEVICE iCAST™ Rx Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2012-10-23 |
| Est. Completion | 2020-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673373
The ClinicalTrials.gov registry entry for NCT01673373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atrium Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iCAST™ Rx Stent System is the first listed.
NCT01673373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673373 about?
NCT01673373 is a clinical study titled "Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension". The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.
What is the current status of trial NCT01673373?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2012-10-23. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT01673373?
The interventions under investigation include: iCAST™ Rx Stent System (DEVICE).
Who is sponsoring clinical trial NCT01673373?
This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.